HCPLive® peer-to-peer panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's healthcare professionals.
A panel of experts discusses vitiligo, its impact on the quality of life, and the role of shared-decision making in managing the disease. Panelists discuss their approach to setting patient expectations and share their enthusiasm about ongoing vitiligo research and therapies on the horizon.
A panel of experts explore the patient journey and unmet needs of patients with treatment resistant depression (TRD), outline treatment strategies for TRD outside of oral antidepressants/antipsychotics and explore strategies to support access to these alternative therapies through improved billing/coding strategies.
Key opinion leaders explore the diagnosis, management, and treatment of attention deficit hyperactivity disorder (ADHD) in the adult population and share key insights on the evolving treatment landscape.
A panel of experts discuss the diagnosis, management, and treatment options for peripheral artery disease (PAD), as well as what can be done to improve the treatment landscape.
Expert panelists reflect on the selection and use of recently approved treatments, including interleukin pathway inhibitors, for type 2 inflammation in atopic dermatitis.
A panel of experts explore the impact of sickle cell disease on patients and discuss treatment and management considerations.
A panel of experts discuss their knowledge and experiences treating patients with psoriatic arthritis.
A panel of eye care specialists provide insight on the diagnosis, clinical manifestations, and treatment options for patients who have wet AMD.
Expert panelists review insomnia diagnosis and clinical manifestations, non-pharmacological management, pharmacological treatment options, and new agents on the horizon.
A panel of experts discusses the clinical management of diabetic macular edema and the available and upcoming treatment options.
Expert panelists provide insight on the relationship between the gut microbiome and c difficile, leading to the development of novel therapeutic approaches for infection.
Anthony M. Turkiewicz, MD; Leonard H. Calabrese, DO; Sheetal Desai, MD; and Ana-Maria Orbai, MD, MHS, share insight on currently available biologic therapies, diagnostic strategies, and real-world case scenarios of psoriatic arthritis.
In this Peer Exchange, a panel of specialists examine the current and developing treatment options for age-related macular degeneration, with a focus on faricimab.
Key insight from a panel of retinal disease specialists on the role of VEGF inhibitors in managing retinal diseases, including non-proliferative diabetic retinopathy.
Expert panelists review novel agents and best practices that have improved the treatment landscape of atopic dermatitis.
An expert multidisciplinary panel reacts to the availability of newer therapies and various strategies that may minimize adverse effects, including weight gain, from HIV treatment.
An overview of treatment advances for atopic dermatitis and the role of the nurse practitioner and physician assistant in educating patients on treatment options and helping them gain access to more novel approaches.
Experts provide an overview on the management of inflammatory bowel disease using biologics and discussing their safety and efficacy data presented at the DDW Virtual 2021.
Expert panelists provide a lively discussion on currently available pharmacologic and non-pharmacologic treatment approaches in the management of hypoglycemic episodes in patients with diabetes.
A panel discussion focused on advances in the management of treatment-resistant depression and the fundamentals of certified treatment centers for the dispensing and administration of esketamine.
Experts discuss challenges in sickle cell disease along with the available standard of care and newer FDA-approved agents used in the management of the disease.
Expert cardiologists provide a brief overview of the standard of care for lipid disorders and focus on a rapidly emerging, newer treatment option for managing dyslipidemia.
Joe Avelino, RN, BSN, MHSA, CPHQ; Rahn Bailey, MD, DFAPA; and Henry Nasrallah, MD discuss the benefits of long-acting injectables in the management of schizophrenia and system protocols that are in place for the use of long-acting injectables in an institutional setting.
Experts discuss challenges and recent guidance provided by national agencies pertaining to the opioid crisis, in addition to providing real world examples of how to implement effective management strategies into clinical practice.
Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, provide insight on the management of atopic dermatitis and the importance of a multidisciplinary approach to care.
